Innovation Institute Blog

Matt Kesinger stands outside the offices of Forest Devices in Pittsburgh’s along Fifth Avenue in Pittsburgh’s Uptown neighborhood with the company’s prototype stroke diagnosis device strapped to his shoulder.

A potential treatment for preventing fibrosis following a heart attack and for inhibiting the cell signaling that triggers cancer metastasis; a technology platform to prevent the buildup of biological materials, or foulants, on surfaces such as medical implants; and novel biological and chemical sensors based on carbon nanomaterials, have been selected as recipients of the Chancellor’s Innovation Commercialization Funds.

A potential treatment for preventing fibrosis following a heart attack and for inhibiting the cell signaling that triggers cancer metastasis; a technology platform to prevent the buildup of biological materials, or foulants, on surfaces such as medical implants; and novel biological and chemical sensors based on carbon nanomaterials, have been selected as recipients of the Chancellor’s Innovation Commercialization Funds.

A potential treatment for preventing fibrosis following a heart attack and for inhibiting the cell signaling that triggers cancer metastasis; a technology platform to prevent the buildup of biological materials, or foulants, on surfaces such as medical implants; and novel biological and chemical sensors based on carbon nanomaterials, have been selected as recipients of the Chancellor’s Innovation Commercialization Funds.

A potential treatment for preventing fibrosis following a heart attack and for inhibiting the cell signaling that triggers cancer metastasis; a technology platform to prevent the buildup of biological materials, or foulants, on surfaces such as medical implants; and novel biological and chemical sensors based on carbon nanomaterials, have been selected as recipients of the Chancellor’s Innovation Commercialization Funds.